Nyxoah SA (NYXH) Stock Analysis

Company Overview

Nyxoah SA (NYXH) carries a market capitalisation of $164.98M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 153.

The most recent close on file for NYXH is $1.62, dated September 4, 2026. That is −$0.14 (−7.95%) against the previous close. The 52-week range on file runs from $1.26 to $6.88. The latest close sits 28.57% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $10.02M. That is +121.63% against the prior fiscal year, when revenue was $4.52M. The same year closed with a net loss of $90.09M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −2.36.

Across the 4 fiscal years on file, revenue moves from $3.08M in 2022 to $10.02M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 7.62 times revenue. On price-to-sales that is 155.9% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.96. Daily returns over the trailing 5 years annualize to a volatility of 75.08%. The trailing one-year price return is −71.58%. Across 5 years the annualized return works out at −44.56%.

Growth & Income

The record shows no dividend for NYXH.

Across the complete calendar years on file, 2024 returned +72.41% and 2022 returned −78.30%. Of the 4 complete calendar years on file, 1 finished higher. So far in 2026 the price is −64.78%.